Soliqua vs Wegovy

Soliqua is a once-daily injection for type 2 diabetes that contains the active ingredient lixisenatide, made by Sanofi. Wegovy is a once-weekly injection for obesity and cardiovascular risk reduction that contains the active ingredient semaglutide, made by Novo Nordisk. Both are given under the skin, but they use different drugs, treat different conditions, and have different dosing schedules.

AI summary of the sources below.